Holders — by stockHoldings — by fund
Prosight Management, LP
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 1617201
$580.4M
disclosed book value
36
positions
10.6%
largest position share
Positions, as of 2026-06-30
top 36 of 36 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | LKFTLAKEFRONT BIOTHERAPEUTICS NV | 2.0M | $61.3M | 10.6% |
| 2 | JANXJANUX THERAPEUTICS INC | 3.8M | $58.4M | 10.1% |
| 3 | NKTRNEKTAR THERAPEUTICS | 810,000 | $56.5M | 9.7% |
| 4 | BSXBOSTON SCIENTIFIC CORP | 1.3M | $54.2M | 9.3% |
| 5 | STTKSHATTUCK LABS INC | 6.0M | $41.3M | 7.1% |
| 6 | INSMINSMED INC | 375,609 | $40.0M | 6.9% |
| 7 | ALNYALNYLAM PHARMACEUTICALS INC | 98,080 | $29.5M | 5.1% |
| 8 | SNDXSYNDAX PHARMACEUTICALS INC | 1.2M | $26.2M | 4.5% |
| 9 | KURAKURA ONCOLOGY INC | 2.0M | $22.2M | 3.8% |
| 10 | ALKERMES PLC | 394,389 | $20.7M | 3.6% |
| 11 | IRTCIRHYTHM HOLDINGS INC | 165,500 | $19.7M | 3.4% |
| 12 | VEEVVEEVA SYS INC | 106,200 | $18.8M | 3.2% |
| 13 | ZYMEZYMEWORKS INC | 674,434 | $17.6M | 3% |
| 14 | ABVXABIVAX SA | 107,394 | $14.3M | 2.5% |
| 15 | CRNXCRINETICS PHARMACEUTICALS IN | 374,666 | $14.0M | 2.4% |
| 16 | MLYSMINERALYS THERAPEUTICS INC | 449,795 | $12.1M | 2.1% |
| 17 | ADC THERAPEUTICS SA | 7.8M | $8.4M | 1.4% |
| 18 | ICUIICU MED INC | 51,000 | $7.5M | 1.3% |
| 19 | ISRGINTUITIVE SURGICAL INC | 17,000 | $6.8M | 1.2% |
| 20 | CRBPCORBUS PHARMACEUTICALS HLDGS | 650,000 | $6.1M | 1.1% |
| 21 | PRCTPROCEPT BIOROBOTICS CORP | 268,269 | $6.1M | 1% |
| 22 | WGSGENEDX HOLDINGS CORP | 85,500 | $5.9M | 1% |
| 23 | OPCHOPTION CARE HEALTH INC | 270,716 | $5.7M | 1% |
| 24 | OKURONKURE THERAPEUTICS INC | 978,992 | $4.5M | 0.8% |
| 25 | EBSEMERGENT BIOSOLUTIONS INC | 459,952 | $3.9M | 0.7% |
| 26 | PFEPFIZER INC | 135,366 | $3.3M | 0.6% |
| 27 | KIDSORTHOPEDIATRICS CORP | 157,500 | $3.0M | 0.5% |
| 28 | RCKTROCKET PHARMACEUTICALS INC | 700,000 | $2.4M | 0.4% |
| 29 | ANTXAN2 THERAPEUTICS INC | 474,638 | $2.3M | 0.4% |
| 30 | PLRXPLIANT THERAPEUTICS INC | 1.4M | $1.6M | 0.3% |
| 31 | TECXTECTONIC THERAPEUTIC INC | 39,731 | $1.4M | 0.2% |
| 32 | MEIRAGTX HLDGS PLC | 90,000 | $1.2M | 0.2% |
| 33 | EFOREVERFORTH INC | 67,500 | $1.2M | 0.2% |
| 34 | RNTXREIN THERAPEUTICS INC | 1.1M | $1.1M | 0.2% |
| 35 | COYACOYA THERAPEUTICS INC | 170,000 | $994,500 | 0.2% |
| 36 | IMRXIMMUNEERING CORP | 36,861 | $183,936 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.